Ulcerative Colitis: Clinical and Endoscopic Characteristics and Therapeutic Management in the Colombian Caribbean Region
DOI:
https://doi.org/10.22516/25007440.1412Keywords:
Ulcerative colitis, inflammatory bowel disease, colitisAbstract
Introduction: Ulcerative colitis (UC) has shown a global increase in incidence in developing countries. In Colombia, its prevalence exceeds that of Crohn’s disease, and adherence to clinical practice guidelines remains uncertain, making regional epidemiological characterization essential.
Objective: To identify clinical patterns, histoendoscopic findings, and therapeutic approaches in patients with UC at a referral center in Barranquilla, Colombia, in 2024.
Methods: A retrospective descriptive case series was conducted, including 49 adults with histologically confirmed UC treated at a referral center in the Colombian Caribbean region during 2024. Sociodemographic, clinical, endoscopic, histological, and therapeutic variables were collected and analyzed.
Results: A total of 49 patients were evaluated (mean age: 53.9 years), with a predominance of females and urban residents. Low consumption of alcohol, nonsteroidal anti-inflammatory drugs, and oral contraceptives was observed. The absence of prior appendectomy and the presence of conditions such as anxiety and depression were notable findings. Inflammatory activity assessed by acute-phase reactants and rectal bleeding were frequent. Anatomical extension predominantly corresponded to left-sided colitis and pancolitis, and endoscopic severity was mainly classified as Mayo score 2. Monotherapy with 5-ASA was the most commonly used regimen, with a transition toward combination therapy as endoscopic severity increased and more specific therapeutic regimens were required.
Conclusions: The findings highlight heterogeneity in the management of UC and a discordance between clinical and endoscopic severity classifications. Integrating demographic, clinical, and histoendoscopic data is essential to optimize treatment strategies and clinical outcomes within the Colombian healthcare context.
Downloads
References
Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951-65. https://doi.org/10.1001/jama.2023.15389
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769-78. https://doi.org/10.1016/S0140-6736(17)32448-0
Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13(3):e065186. https://doi.org/10.1136/bmjopen-2022-065186
Juliao-Baños F, Kock J, Arrubla M, Calixto O, Camargo J, Cruz L, et al. Tendencias en la epidemiología de la enfermedad inflamatoria intestinal en Colombia por demografía y región utilizando una base de datos de reclamaciones representativa a nivel nacional y caracterización del fenotipo de la enfermedad inflamatoria intestinal en una serie de casos de pacientes colombianos. Medicina (Baltimore). 2021;100(7):e24729. https://doi.org/10.1097/MD.0000000000024729
Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. United European Gastroenterol J. 2022;10(10):1047-53. https://doi.org/10.1002/ueg2.12319
Narula N, Wong ECL, Pray C, Marshall JK, Rangarajan S, Islam S, et al. Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDs with inflammatory bowel disease: results from the Prospective Urban Rural Epidemiology (PURE) Study. Clin Gastroenterol Hepatol. 2023;21(10):2649-59.e16. https://doi.org/10.1016/j.cgh.2022.11.037
D’Amico F, Magro F, Dignass A, Al Awadhi S, Gutierrez Casbas A, Queiroz NSF, et al. Practical management of mild-to- moderate ulcerative colitis: an international expert consensus. Expert Rev Gastroenterol Hepatol. 2024;18(8):421-30. https://doi.org/10.1080/17474124.2024.2397650
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106. https://doi.org/10.1136/gutjnl-2019-318484
Juliao-Baños F, Grillo-Ardila CF, Alfaro I, Andara-Ramírez MT, Avelar-Escobar O, Barahona-Garrido J, et al. Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population. Rev Gastroenterol Mex (Engl Ed). 2022;87(3):342-61. https://doi.org/10.1016/j.rgmxen.2022.04.006
Juliao-Baños F, Torres-Amaya M, Otero-Regino W, Vallejo MT, Galiano MT, Feliciano J, et al. Guía para el manejo de colitis ulcerativa en población adulta (actualización). Rev Colomb Gastroenterol. 2020;35(Supl 2):2-62. https://doi.org/10.22516/25007440.636
Ministerio de Salud de la República de Colombia. Resolución 008430 de 1993. Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Diario Oficial. 1993;(40.885) [Internet]. Colombia: Ministerio de Salud; 1993 [consultado el 14 de agosto de 2023]. Disponible en: https://minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.pdf.
Juliao-Baños F, Puentes F, López R, Saffon MA, Reyes G, Parra V, et al. Characterization of inflammatory bowel disease in Colombia: results of a national register. Caracterización de la enfermedad inflamatoria intestinal en Colombia: resultados de un registro nacional. Rev Gastroenterol Mex (Engl Ed). 2021;86(2):153-62. https://doi.org/10.1016/j.rgmx.2020.05.005
Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol. 2016;22(27):6296-317. https://doi.org/10.3748/wjg.v22.i27.6296
Casey K, Lopes EW, Niccum B, Burke K, Ananthakrishnan AN, Lochhead P, et al. Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts. Aliment Pharmacol Ther. 2022;55(2):225-33. https://doi.org/10.1111/apt.16731
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF, Sands BE. Ulcerative colitis. Lancet. 2017;389(10080):1756-70. https://doi.org/10.1016/S0140-6736(16)32126-2
Graff LA, Geist R, Kuenzig ME, Benchimol EI, Kaplan GG, Windsor JW, et al. The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2023;6(Suppl 2):S64-S75. https://doi.org/10.1093/jcag/gwad012
Singh S, Ananthakrishnan AN, Nguyen NH, Cohen BL, Velayos FS, Weiss JM, et al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023;164(3):344-72. https://doi.org/10.1053/j.gastro.2022.12.007
Gompertz M, Sedano R. Manifestaciones clínicas y endoscópicas en enfermedad inflamatoria intestinal. Rev Med Clin Condes. 2019;30(4):273-282. https://doi.org/10.1016/j.rmclc.2019.06.002
Singh S, Loftus EV Jr, Limketkai BN, Haydek JP, Agrawal M, Scott FI, et al. Guía de práctica clínica de AGA Living sobre el manejo farmacológico de la colitis ulcerosa de moderada a grave. Gastroenterología. 2024;167(7):1307-1343. https://doi.org/10.1053/j.gastro.2024.10.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 1410 |
| Galley views | 600 |
| PDF Views | 483 |
| HTML views | 0 |
| Other views | 117 |














